Beam Therapeutics Inc. — Form 10-Q

Beam Therapeutics adopted a Second Amended and Restated 2019 Employee Stock Purchase Plan allowing eligible employees to purchase company stock via payroll deductions at 85% of the lower of grant-date or exercise-date fair market value. The plan authorizes an initial pool of 465,000 shares, auto-increasing annually (up to 5.1M aggregate) by the lesser of 1% of outstanding shares or Board-determined amount. Participants can contribute 1–20% of eligible compensation per payroll period, with a $25,000 annual fair market value limit per Section 423(b)(8) of the Tax Code and a 5,000-share per-exercise limit. No material financial commitment or headcount data disclosed; this is a standard ESPP governance document.